Fentanyl produces a minimal reduction in the minimum alveolar concentration of sevoflurane to prevent response to a verbal command in 50% of patients (MAC[awake]) at low but analgesic plasma concentrations. The reduction in MAC(awake), however, is still unknown at higher fentanyl concentrations. The reduction in the MAC of sevoflurane by fentanyl has not been described accurately. The purpose of this study was to determine the MAC(awake) and MAC reduction of sevoflurane by fentanyl.
Ninety-two patients were randomly allocated to seven fentanyl concentration groups (target plasma concentrations of 0, 1, 1.5, 3, 6, 10, and 14 ng/ml). Responses to verbal command were observed for MAC(awake) assessment at predetermined sevoflurane concentrations. Thereafter, in patients whose target fentanyl concentration was 0 to 10 ng/ml, responses to skin incision were observed for MAC assessment at new steady-state sevoflurane concentrations. The reduction in the MAC(awake) and MAC of sevoflurane by the measured fentanyl concentration was calculated.
There was an initial steep reduction in the MAC of sevoflurane by fentanyl, with 3 ng/ml resulting in a 59% MAC reduction. A ceiling effect was observed, with 10 ng/ml providing only a further 17% reduction in MAC. The initial reduction in MAC(awake) was not as steep as that in MAC. Fentanyl reduced MAC(awake) by approximately 24% at a plasma concentration of 3 ng/ml. Although the reduction curve of MAC(awake) was parabolic, no manifest ceiling effect was observed at concentrations administered in the present study.
The reduction in sevoflurane requirements for loss of consciousness and skin incision by fentanyl was determined. Fentanyl reduced both requirements, but the mode of the reduction was not comparable.
No anesthetic drug is commonly used alone to provide all the necessary components of general anesthesia. A previous study showed that sevoflurane has a potent hypnotic action, but its analgesic potency is low. The use of fentanyl, which has a potent analgesic effect, in combination with sevoflurane seems reasonable to provide two important components for clinical anesthesia: loss of consciousness and analgesia. It is important to define the interactions among the different anesthetics that may be used in combination for two clinically important endpoints, loss of consciousness and loss of response to skin incision. For the volatile anesthetics, the minimum alveolar concentration (MAC) for achieving a 50% probability of movement in response to a skin incision provides one measure of anesthetic potency. Similarly, the MAC for achieving a 50% probability of no response to a verbal command (MAC sub awake) provides one measure of hypnotic potency. Previously we showed that the MACawakeof sevoflurane is not markedly reduced by low plasma concentrations (1 ng/ml and 2 ng/ml) of fentanyl. In contrast, fentanyl has been reported to reduce the MAC of other volatile anesthetics, such as desflurane and isoflurane, even at concentrations less than 1 ng/ml. [3,4]
This study was designed to determine the reduction of the MAC and MACawakeof sevoflurane by fentanyl.
Materials and Methods
After approval was granted from the ethics committee of our department, informed consent to participate in this study was acquired from all patients. The study group included 92 patients of both sexes, who were classified as American Society of Anesthesiologists physical status I or II, aged 20–60 yr, and scheduled for elective surgery. The following patients were excluded from the study:(1) those in whom an inhalational induction was contraindicated;(2) those who had any significant cardiovascular respiratory, hepatic, or renal disease;(3) those who were receiving medications known to affect MAC, or MACawake, or who had a history of alcohol or drug abuse; and (4) those in whom any sudden movement may have been dangerous.
Each of the first 80 patients was initially randomly allocated into one of six different fentanyl concentration groups for MACawakemeasurement according to a randomization scheme (Figure 1). Group 1 received no fentanyl, whereas groups 2 to 6 each received predicted target plasma concentrations of 1, 1.5, 3, 6, and 10 ng/ml. An additional group of 12 patients was added at the conclusion of the study to more clearly define the MACawakereduction at fentanyl concentrations greater than 10 ng/ml. The target concentration of the additional group was 14 ng/ml. The patients fasted for at least 8 h before surgery and received no premedicating drugs. Before induction of anesthesia, a venous catheter was inserted into one arm for drug administration, and another venous catheter was inserted into the other arm for blood sampling. Fentanyl was administered using a pharmacokinetic model-driven, computer-controlled continuous infusion device capable of administering intravenous drugs to achieve constant target plasma concentrations. The computer-controlled continuous infusion device consisted of a NEC 9801 laptop computer and an ATOM 1235 infusion pump (Tokyo, Japan). The pharmacokinetic parameters used in computer-controlled continuous infusion for fentanyl are based on a study by Shafer et al. 
Anesthesia was induced with sevoflurane and oxygen first during spontaneous ventilation and then during manual ventilation. Fentanyl was infused according to the predetermined randomization scheme. Vecuronium was administered at 0.02 mg/kg for precurarization. Paralysis was induced by 1.5 mg/kg succinylcholine, which was followed by tracheal intubation. During laryngoscopy, the trachea and larynx were sprayed with 2 mg/kg 4% topical lidocaine to abolish tracheal and laryngeal stimuli created by the endotracheal tube.
Measurement of MAC sub awake
Immediately after tracheal intubation, the inspired concentration of sevoflurane was adjusted to maintain the measured end-tidal concentration at a constant value according to a second predetermined randomization scheme (Figure 1). These sevoflurane concentrations were chosen to provide a range that would impart both adequate and inadequate anesthesia at each fentanyl concentration, and they were based on previous data. [2,6]End-tidal concentrations of sevoflurane and carbon dioxide were measured continuously using an infrared multigas anesthetic analyzer (Capnomac Ultima; Datex, Helsinki, Finland). Gas samples were collected via a Teflon catheter placed at the tracheal end of the endotracheal tube. Patients' lungs were mechanically or manually ventilated to normocapnia, and body temperature was maintained above 35.5 [degree sign] Celsius.
To ensure rapid equilibration between the plasma and effect compartment, for the first 6 min the infusion was adjusted to achieve a fentanyl concentration twice the predetermined target concentration according to the half-time (ke0) for equilibration between blood and the brain (6.4 min). Thereafter the target concentration of fentanyl was returned to the value to which the patient had been randomized to. After maintaining the end-tidal sevoflurane concentration for 15 min, patients were judged to be awake or asleep by having their names called loudly and being instructed to open their eyes or move their heads. If patients could open their eyes or move their heads, they were judged awake. If they did not, a return of neuromuscular function was confirmed by a peripheral nerve stimulator. The mean time from starting fentanyl infusion to verbal command was 27 min (range, 22–35 min). Blood samples were taken 5 min before and just after MACawakeassessment to ensure that steady plasma fentanyl concentration were being maintained.
Measurement of Minimum Alveolar Concentration
After the above assessment, the end-tidal sevoflurane concentration was either maintained or changed to the predetermined concentration according to the scheme for skin incision (Figure 2). These sevoflurane concentrations were chosen to provide a range that would impart both adequate and inadequate anesthesia at each fentanyl concentration, and they were based on data from previous MAC reduction studies. [3,4]After maintaining the end-tidal concentration constant for more than 15 min, blood samples were taken 5 min before and just after skin incision. The mean time from starting fentanyl infusion to skin incision was 50 min (range, 45–75 min). The average time lag between the MACawakeand MAC determinations was 23 min (range, 20–45 min). Patients were observed for gross purposeful movement for 60 s after skin incision. Coughing, chewing, or swallowing was not considered purposeful movement.
Blood Sample Analysis
Blood samples were allowed to clot for 15 min, and the serum was separated and frozen at -70 [degree sign] Celsius until assay. The fentanyl concentration was determined using a previously described radioimmunoassay technique. The assay was linear over the concentrations measured, with a lower limit of detection of 0.13 ng/ml and a coefficient of variation of less than 10%. Plasma lidocaine concentration at the time of MACawakeassessment was measured with a high-performance liquid chromatographic assay sensitive to 4 ng/ml. The coefficient of variation of both assays was less than 10% over the concentration range measured. All assays were performed in duplicate. If the two measurements differed by more than 10%, the sample was reassayed.
The pre- and postassessment samples were compared to ensure that a steady concentration was being maintained. Only paired samples that had concentrations within +/- 35% of each other were included in the statistical analysis. From these paired samples, only the postassessment fentanyl concentrations were used for analysis.
The technique used to determine the MACawakeand MAC of sevoflurane in the absence of fentanyl was adapted from the method described by Waud. We estimated the reduction of sevoflurane MAC sub awake and MAC by fentanyl using a multiple independent variable logistic regression model with the natural log of the drug concentration as predictor variables. In addition, the product of the log of the drug concentrations was included in the model to determine an interaction (deviation from linearity) effect. The concentration of sevoflurane required to prevent response to skin incision in 95% of patients (MAC95) and the concentrations required to prevent response to verbal command in 5% and 95%(MACawake95and MACawake5, respectively) were also determined.
Ninety-two patients (39 men, 53 women) were enrolled in the study. Their average age was 42.9 +/- 10.6 (SD) yr (range, 21–60 yr); their average weight was 58.6 +/- 12.1 (SD) kg (range, 40–78 kg). Postassessment fentanyl concentrations, which were used in the statistical analyses, ranged from 0 to 15.8 ng/ml.
Mac sub awake Determination
Eight patients were excluded from the MACawakeanalysis because pre- and postassessment paired samples did not have concentrations within +/- 35% of each other. In addition, four patients were excluded because of uncontrollable severe movement during maintaining steady-state concentration of sevoflurane. Thus the results of 80 patients are analyzed. Of 80 patients, 18 did not receive fentanyl.
The MACawakedetermined from the patients not receiving fentanyl was 0.62 +/- 0.03%(SE). The MACawake5was 0.71%. Based on the model that included both patients receiving and not receiving fentanyl, the predicted MACawakefor sevoflurane alone was 0.65%. The MACawakewas reduced with increasing plasma fentanyl concentrations. The reduction of MACawakewas approximately 10%, or 24% at fentanyl concentrations of 1 or 3 ng/ml, respectively. A 50% reduction in MACawakewas produced by 7.3 ng/ml fentanyl (Figure 3(A)).
Plasma lidocaine concentration at the time of MACawakeassessment was 1.4 +/- 0.24%(SD) micro gram/ml.
Minimum Alveolar Concentration Determination
Two patients were excluded from the MAC analysis because pre- and postassessment paired samples did not have concentrations within +/- 35% of each other. Thus the results of 78 patients were analyzed. Of 78 patients, 20 did not receive fentanyl. The MAC determined from the patients not receiving fentanyl was 1.84 +/- 0.08%(SE). The MAC95was 2.21%. Based on the model that included patients both receiving and not receiving fentanyl, the predicted MAC for sevoflurane alone was 1.77%. The MAC was markedly reduced with increasing fentanyl concentration. The reduction of MAC was approximately 38%, or 59% at fentanyl concentrations of 1 or 3 ng/ml, respectively. A 50% reduction in MACawakewas produced by 1.8 ng/ml fentanyl. A ceiling effect was observed, with 10 ng/ml providing only a further 17% reduction in MAC (Figure 3(B)).
Our purpose was to determine the reduction of end-tidal sevoflurane concentrations at two different end-points: loss of response to a verbal command and loss of response to skin incision by fentanyl administered using a pharmacokinetic model-driven computer-controlled continuous infusion. The MACawakeof sevoflurane obtained in this study was 0.62%. This is similar to the determined sevoflurane MACawakein our previous study. In that investigation, we showed that fentanyl significantly reduced the MACawakeof sevoflurane at a plasma concentration of 2 ng/ml. However, this reduction was much smaller than that reported for the MAC reduction of other volatile anesthetics by fentanyl. The interaction of sevoflurane along a continuum of fentanyl concentration is accurately calculated using logistic regression analysis. An initial steep reduction, which was observed in the MAC reduction of volatile anesthetics by fentanyl, was not observed in the MACawakereduction. The results correspond with our previous findings for MACawake. The MACawakereduction by 2 ng/ml of fentanyl was approximately 15%, whereas the MAC reduction by the same fentanyl concentration was approximately 50%. The initial reduction in MACawakewas not as steep as that in MAC. Although the reduction curve of MACawakewas parabolic, no obvious ceiling effect was observed at concentrations administered in the present study.
The Cp50asleepis the plasma concentration of intravenous anesthetics for achieving 50% probability of no movement in response to a verbal command. Fentanyl did not significantly alter the Cp50asleepvalue of thiopental at a plasma concentration of 1.27 ng/ml. Low doses of fentanyl (1.5 micro gram/kg) resulted in a small decrease in the thiopental dose (13%), whereas larger doses (4 micro gram/kg) resulted in a greater decrease in the thiopental requirement for the induction of anesthesia. [13,14]Even a dose of 1.5 micro gram/kg will result in a peak plasma and effect compartment concentration exceeding 2 ng/ml. A fentanyl concentration of 3 ng/ml reduced Cp50asleepof propofol by approximately 40%. Increasing fentanyl concentration beyond 3 ng/ml produced a small further reduction in propofol Cp50asleep. This ceiling phenomenon in the propofol study was not consistent with that observed in the present sevoflurane study. Both thiopental and propofol have a potent hypnotic action, but their analgesic potency is low, similar to that with sevoflurane. The magnitude of the reduction in Cp50asleepor MACawakeof these potent hypnotics by 2 ng/ml fentanyl was similar at approximately 15–20%. Streisand et al. suggested that intravenous fentanyl produced unconsciousness, even when administered without other concomitant anesthetics. At an estimated effect site fentanyl concentration of 9.7 ng/ml, 50% of patients did not respond to command in their study. The results of the present study suggest that at a fentanyl concentration of 9.7 ng/ml, more than 50% of patients would respond to verbal command. Streisand et al. administered fentanyl in a single bolus, whereas we used the computer-controlled continuous infusion technique. This methodologic difference may explain the discrepancy. Plasma lidocaine was reported not to decrease the MACawakeof isoflurane at the plasma concentration of 2.09 micro gram/ml. Because the mean plasma lidocaine concentration at the MACawakeassessment was 1.4 micro gram/ml, the effect of plasma lidocaine on the MACawakeobtained in this study was probably minimal.
Fentanyl produces an initial steep decrease in the MAC of sevoflurane. This decrease then reaches a plateau with minimal further reduction in the MAC of sevoflurane at a fentanyl concentration greater than 3 ng/ml of fentanyl. Doubling the plasma concentration from 3 ng/ml to 6 ng/ml only produces a further 11% reduction in MAC. This rapid flattening of the curve in the plot of plasma fentanyl concentration versus the MAC of sevoflurane suggests that a ceiling effect exists in the action of fentanyl on the reduction. These findings are relatively similar to previous studies for isoflurane and desflurane. [3,4]In the present study, a 50% reduction in MAC was produced by 1.8 ng/ml fentanyl, which was close to the amount that produced a 50% MAC reduction of isoflurane or desflurane.
Although we did not measure lidocaine concentrations at the time of MAC determination, the average plasma lidocaine concentration should be less than 1 micro gram/ml because an average of 50 min had elapsed after topical lidocaine administration. Himes et al. reported that the effect of plasma lidocaine on MAC for halothane revealed little or no change at concentrations less than 3 micro gram/ml. The effect of plasma lidocaine on the MAC obtained in this study was probably minimal.
Our data show that fentanyl reduced the sevoflurane requirements for loss of response to both verbal command and skin incision. The mode of reduction was, however, different between the two endpoints. Some observations suggest that motor responses to a noxious stimulus may be primarily mediated by subcortical structures, including the spinal cord in lower animals. [19,20]In contrast, purposeful responsiveness to a verbal command apparently needs intact cortex function. Fentanyl, therefore, probably acts at different sites in producing its effect on the MAC and MACawakereductions. The difference in sites of action may explain the difference in the mode of reduction by fentanyl between the MAC and MACawake.
The method used to measure MACawakewas initially defined and validated by Stoelting et al. They measured MACawakeafter operation in patients with tracheas intubated. We chose MAC sub awake as one measurement of hypnotic potency for the purpose of assessing interaction in hypnosis between sevoflurane and fentanyl. The MACawakedefined by Stoelting et al. may not reflect a pure hypnotic potency of a volatile anesthetic because they measured MACawakein intubated patients without trying to remove any stimuli created by an endotracheal tube. Therefore, the MACawakedefined by Stoelting et al. indicates not only hypnotic potency but also antitussive potency of a volatile anesthetic and may not be comparable to the MACawakewe determined here.
We could not determine the MACawakein the absence of an endotracheal tube because of rigidity caused by high concentrations of fentanyl. Thus an endotracheal tube was placed in all patients to facilitate ventilation. To prevent the effect of the noxious stimulus provided by the endotracheal tube on the assessment of MACawake, a topical lidocaine spray was used. The efficacy of this lidocaine spray in inhibiting the noxious stimulus was not always guaranteed, because four patients at low sevoflurane or fentanyl concentrations demonstrated bucking on the endotracheal tube. We excluded these four patients from the MACawakeanalysis because topical lidocaine anesthesia seemed unable to eliminate stimulus created by the endotracheal tube in these four patients. Both sevoflurane and fentanyl can, at higher concentrations, ablate this bucking response to the endotracheal tube. Thus it is possible that higher concentrations of sevoflurane and fentanyl inhibited this response, but because of the endotracheal tube patients were maintained awake at higher concentrations of these agents than would have occurred in the absence of potent stimulus such as the endotracheal tube. Therefore the data may overestimate the true MACawakeconcentration, but the presence of an endotracheal tube and topical lidocaine spray is unlikely to have affected the shape of the interaction curve for MACawake.
To ensure adequate anesthesia to all patients, most clinicians will administer an anesthetic to achieve a sevoflurane and fentanyl concentration at which 95% of patients do not respond to skin incision. For awakening, the sevoflurane concentration must decrease to the MACawakeconcentration. Thus awakening times can be estimated from the time it takes for the sevoflurane concentration to decrease from the MAC95value of any combination to the MACawake95value for any combination. Based on this, the time to awakening will occur most rapidly when a fentanyl concentration of 3.6 ng/ml is used. Adequate recovery, however, depends on return of consciousness and on adequate spontaneous ventilation. Fentanyl concentrations greater than 2–3 ng/ml have a high likelihood of producing clinically significant respiratory depression. Thus the fentanyl concentration will need to decrease from 3.6 ng/ml to less than 2 ng/ml (approximately 50%). The time for fentanyl to decrease by 50% varies according to the duration of its infusion and can be estimated from its context-sensitive half-time but is invariably longer than the time for the sevoflurane concentration to decrease from the MAC95value to the MACawake95value (approximately 5–10 min). Nearly maximal MAC reduction has already occurred using concentrations of fentanyl between 1–2 ng/ml without clinically significant MACawakereduction; that is, a decrease in sevoflurane from 1.5% to 0.5% is required to move from adequate anesthesia to awakening in 95% of patients. The concomitant use of fentanyl at these concentrations with sevoflurane will provide both rapid recovery from anesthesia and a low risk of the occurrence of clinically significant respiratory depression.
In conclusion, we determined the MACawakeand MAC reductions of sevoflurane by constant plasma fentanyl concentrations. The MAC was markedly reduced by a low concentration of fentanyl up to 3 ng/ml. Increasing higher plasma concentrations from 3 ng/ml produced little further reduction in MAC. Although the reduction curve of MACawakewas parabolic, like that of MAC, the initial reduction in MACawakewas not as steep as that with MAC, and no obvious ceiling effect on MAC awake by fentanyl was observed at concentrations administered in the present study.
The authors thank Dr. Shibutani at New York Medical College for his encouragement and numerous suggestions.